Cluster Headache Study

Cluster headache (CH) has been described as one of the most painful conditions a human can experience.  Its nickname, suicide headache, accurately conveys the sentiment many cluster patients feel when in a cluster cycle. CH can be divided into to groups: those that cluster (that is, the headaches occur for weeks, are then gone for many months, then return.  This is called episodic cluster), and those that no longer cluster (chronic cluster), but rather occur every day without interruption.  Acute therapies include inhaled oxygen and sumatriptan injections, but there are no preventive treatments currently approved by the Food and Drug Administration (FDA).

  •  For our patients with Cluster Headaches, we are currently offering a trial looking into a new delivery system in the treatment of cluster headaches. This study is a single dose study, meaning that any patients who qualify for the trial will use the delivery system of the medication a single time. Anyone enrolled in the study will have up to 50 weeks to treat a cluster attack. Click the button to view information about this study on clinicaltrials.gov. Learn More

At NEICR we’re committed to helping cluster headache patients.  Over the years, we’ve been involved in more cluster studies then just about any other research organization.  Some of these projects have gone on to become fully approved medications by the FDA.

 

If you or someone you know suffers from this devastating condition, please call us at 203-914-1903.  Even if we don’t have an active study that’s a right fit for you, we’ll get your information and contact you as soon as one opens up.

Study procedures at NEICR come at no cost to you, and there may be compensation provided for time and travel.  To enroll or learn more fill out the form below or call us at 203-914-1903.

Use the form below to enroll

Cluster Headache - Clinical Study Enrollment
First
Last
Sending